CLC number: R511
On-line Access: 2024-08-27
Received: 2023-10-17
Revision Accepted: 2024-05-08
Crosschecked: 2020-03-16
Cited: 0
Clicked: 5928
Qin Zhang, Jian Pan, Min-Xing Zhao, Yuan-Qiang Lu. Clinical value of the emergency department in screening and diagnosis of COVID-19 in China[J]. Journal of Zhejiang University Science B, 2020, 21(5): 388-393.
@article{title="Clinical value of the emergency department in screening and diagnosis of COVID-19 in China",
author="Qin Zhang, Jian Pan, Min-Xing Zhao, Yuan-Qiang Lu",
journal="Journal of Zhejiang University Science B",
volume="21",
number="5",
pages="388-393",
year="2020",
publisher="Zhejiang University Press & Springer",
doi="10.1631/jzus.B2010011"
}
%0 Journal Article
%T Clinical value of the emergency department in screening and diagnosis of COVID-19 in China
%A Qin Zhang
%A Jian Pan
%A Min-Xing Zhao
%A Yuan-Qiang Lu
%J Journal of Zhejiang University SCIENCE B
%V 21
%N 5
%P 388-393
%@ 1673-1581
%D 2020
%I Zhejiang University Press & Springer
%DOI 10.1631/jzus.B2010011
TY - JOUR
T1 - Clinical value of the emergency department in screening and diagnosis of COVID-19 in China
A1 - Qin Zhang
A1 - Jian Pan
A1 - Min-Xing Zhao
A1 - Yuan-Qiang Lu
J0 - Journal of Zhejiang University Science B
VL - 21
IS - 5
SP - 388
EP - 393
%@ 1673-1581
Y1 - 2020
PB - Zhejiang University Press & Springer
ER -
DOI - 10.1631/jzus.B2010011
Abstract: Since the global outbreak of severe acute respiratory syndrome (SARS) in 2003, China has gradually built a robust prevention and control system for sudden infectious diseases. All large hospitals have a fever clinic that isolates patients with all kinds of acute communicable diseases as the first line of medical defense. The emergency department, as the second line of medical defense in hospitals, is constantly shouldering the heavy responsibility of screening communicable diseases while also treating all kinds of other non-communicable acute and critical diseases (Zhang et al., 2012; Zhu et al., 2015; Wang et al., 2017; Feng et al., 2018; Lu, 2018; Xu and Lu, 2019). An outbreak of pneumonia of unknown etiology that began in Wuhan city (China) has spread rapidly in China since December 2019 (Huang et al., 2020; WHO, 2020; Zhu et al., 2020). In February 2020, the National Health Commission of China named the disease a novel coronavirus pneumonia (NCP); then, it was formally named the coronavirus disease 2019 (COVID-19) by the World Health Organization (WHO) on Feb. 11, 2020. The Coronavirus Study Group of the International Committee on Taxonomy of Viruses designated this causative virus as SARS coronavirus 2 (SARS-CoV-2). SARS-CoV-2 belongs to the β coronavirus genus, and its pathogenic mechanism has not been clarified, which requires further study. To better understand the clinical characteristics of COVID-19 and more effectively prevent and control this disease, we retrospectively analyzed four representative cases of COVID-19 that had recently been screened and diagnosed in our emergency department.
[1]Bao YP, Sun YK, Meng SQ, et al., 2020. 2019-nCoV epidemic: address mental health care to empower society. Lancet, 395(10224):E37-E38.
[2]Feng MX, Li YN, Ruan WS, et al., 2018. Predictive value of the maximum serum creatinine value and growth rate in acute paraquat poisoning patients. Sci Rep, 8(1):11587.
[3]Huang CL, Wang YM, Li XW, et al., 2020. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506.
[4]Inoue M, Yamaoka K, 2017. Social factors associated with psychological distress and health problems among elderly members of a disaster-affected population: subgroup analysis of a 1-year post-disaster survey in Ishinomaki area, Japan. Disaster Med Public Health Prep, 11(1):64-71.
[5]Lin XQ, Gong ZY, Xiao ZK, et al., 2020. Novel coronavirus pneumonia outbreak in 2019: computed tomographic findings in two cases. Korean J Radiol, 21(3):365-368.
[6]Lu RJ, Zhao X, Li J, et al., 2020. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet, 395(10224):565-574.
[7]Lu YQ, 2018. HIV and paraquat poisoning: fighting fire with fire? J Zhejiang Univ-Sci B (Biomed & Biotechnol), 19(2):168-170.
[8]Pan YY, Guan HX, Zhou SC, et al., 2020. Initial CT findings and temporal changes in patients with the novel coronavirus pneumonia (2019-nCoV):a study of 63 patients in Wuhan, China. Eur Radiol, online.
[9]Soeteman RJH, Yzermans CJ, Kerssens JJ, et al., 2006. The course of post-disaster health problems of victims with pre-disaster psychological problems as presented in general practice. Fam Pract, 23(3):378-384.
[10]To KKW, Tsang OTY, Yip CCY, et al., 2020. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis, online.
[11]Wang HR, Pan J, Shang AD, et al., 2017. Time-dependent haemoperfusion after acute paraquat poisoning. Sci Rep, 7:2239.
[12]WHO (World Health Organization), 2020. Coronavirus. https://www.who.int/health-topics/coronavirus [Accessed on Jan. 21, 2020].
[13]Xie XZ, Zhong Z, Zhao W, et al., 2020. Chest CT for typical 2019-nCoV pneumonia: relationship to negative RT-PCR testing. Radiology, online.
[14]Xu YG, Lu YQ, 2019. Systematic review and meta-analysis of the efficacy and safety of immunosuppressive pulse therapy in the treatment of paraquat poisoning. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 20(7):588-597.
[15]Zhang Q, Wu WZ, Lu YQ, et al., 2012. Successful treatment of patients with paraquat intoxication: three case reports and review of the literature. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 13(5):413-418.
[16]Zhu JY, Pan J, Lu YQ, 2015. A case report on indirect transmission of human rabies. J Zhejiang Univ-Sci B (Biomed & Biotechnol), 16(11):969-970.
[17]Zhu N, Zhang DY, Wang WL, et al., 2020. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med, 382(8):727-733.
Open peer comments: Debate/Discuss/Question/Opinion
<1>